Working across RSA’s global network, Matt comes to the role with over a decade of experience in the financial services sector.
Matt has served as RSA’s financial controller for over a year. His previous experience included managing the finances for a small biotech firm undertaking stage II clinical trials of a new cancer therapy while working full-time as finance director for The Great Pie Shop.
Nick Stephens, CEO of RSA, said: “We believe Matt is well positioned to succeed in this new role given his broad financial knowledge and experience in the life sciences sector. He is already a well-respected member of the RSA team and we therefore feel very lucky that Matt is taking up this new position.”
In his new role, Matt will be responsible for long-term financial planning and will report directly to the CEO and management board. He will oversee RSA’s global budgeting process and manage the company’s financial risk.
Matt said: “Having worked with RSA for over a year now I have gained first-hand understanding of the quality differentiators that set the company apart from its competitors, as well as gaining insight into the company’s long-term goals. I am excited to take on this new level of responsibility and look forward to helping RSA continue to thrive as we emerge from this seemingly difficult economic period.”